Notes - Segment Information, Etc.

Immuno-Biological Laboratories Co., Ltd. - Filing #7244299

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
969,533,000 JPY
964,373,000 JPY
5,160,000 JPY
969,533,000 JPY
JPY
812,850,000 JPY
816,701,000 JPY
3,851,000 JPY
JPY
816,701,000 JPY
Transactions with other segments
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Other items
Depreciation
15,427,000 JPY
15,427,000 JPY
JPY
15,427,000 JPY
JPY
2,333,000 JPY
2,333,000 JPY
JPY
JPY
2,333,000 JPY
Increase in property, plant and equipment and intangible assets
70,259,000 JPY
70,259,000 JPY
JPY
70,259,000 JPY
JPY
21,768,000 JPY
21,768,000 JPY
JPY
JPY
21,768,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.